cilostazol and rolipram

cilostazol has been researched along with rolipram in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's3 (16.67)18.2507
2000's6 (33.33)29.6817
2010's7 (38.89)24.3611
2020's1 (5.56)2.80

Authors

AuthorsStudies
Bristol, JA; Cain, MH; Weishaar, RE1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Akama, T; Baker, SJ; Freund, Y; Hernandez, V; Kimura, R; Maples, KR; Plattner, JJ; Sanders, V; Zhang, YK; Zhou, H1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Huang, YY; Li, Z; Luo, HB; Wu, D; Wu, Y1
Bai, L; Gong, J; Jin, Y; Peng, T; Shi, J; Tong, R; Wei, X; Zhou, Y1
Chai, S; Chen, S; Deng, L; Du, K; Shen, R; Sun, H; Sun, T; Xi, M; Xie, M1
Dousa, TP; Grande, JP; Matousovic, K; Tsuboi, Y; Walker, H1
Nagai, H; Tanaka, H; Uno, T1
Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M1
Hasegawa, T; Hiramatsu, K; Ito, Y; Kitaichi, K; Kume, H; Shibata, E; Shimizu, Y; Suzuki, R; Takagi, K; Takeuchi, M; Yamaki, K; Yoshida, N1
Cone, J; Fong, M; Hensley, J; Kambayashi, J; Liu, Y; Movsesian, MA; Shakur, Y; Yoshitake, M1
Clancy, JP; Cobb, BR; Fan, L; Kovacs, TE; Sorscher, EJ1
Giembycz, MA; Hasala, H; Kankaanranta, H; Moilanen, E; Parkkonen, J1
Adderley, SP; Bowles, EA; Ellsworth, ML; Sprague, RS; Sridharan, M; Stephenson, AH1
Fisher, MJ; Liu, S; Paganini-Hill, A; Yang, F; Yu, C1
Aguirre-Cruz, L; Corona, T; Göttle, P; Hartung, HP; Kremer, D; Küry, P; Rivera, JF; Torres, KJ1
Ammerman, NC; Bishai, WR; Maiga, M; Maiga, MC; Murphy, R; Polis, M; Siddiqui, S; Tounkara, A1

Reviews

4 review(s) available for cilostazol and rolipram

ArticleYear
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity

1985
Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease.
    Journal of medicinal chemistry, 2018, 07-12, Volume: 61, Issue:13

    Topics: Alzheimer Disease; Animals; Cognition; Humans; Phosphodiesterase Inhibitors

2018
Inhibitors of phosphodiesterase as cancer therapeutics.
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neoplasms; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2018
Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.
    European journal of medicinal chemistry, 2022, Mar-15, Volume: 232

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alzheimer Disease; Animals; Cognition; Cyclic GMP; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases

2022

Other Studies

14 other study(ies) available for cilostazol and rolipram

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.
    Bioorganic & medicinal chemistry letters, 2009, Apr-15, Volume: 19, Issue:8

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatitis, Atopic; Dermatologic Agents; Edema; Humans; Mice; Psoriasis; Structure-Activity Relationship; U937 Cells

2009
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
    The Journal of laboratory and clinical medicine, 1997, Volume: 130, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Division; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Down-Regulation; Folic Acid; Isoenzymes; Kidney Tubules; Male; Phosphodiesterase Inhibitors; Proliferating Cell Nuclear Antigen; Pyrrolidinones; Quinazolines; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Tetrazoles

1997
Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs.
    General pharmacology, 1998, Volume: 30, Issue:2

    Topics: Acetylcholine; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cilostazol; Guinea Pigs; Isoenzymes; Lipopolysaccharides; Male; Neutrophils; Phosphodiesterase Inhibitors; Pyrazines; Pyrrolidinones; Quinolines; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha

1998
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
    Multiple sclerosis (Houndmills, Basingstoke, England), 1999, Volume: 5, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines

1999
Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells.
    Clinical and experimental immunology, 2001, Volume: 126, Issue:3

    Topics: Adult; Asthma; Cilostazol; Colforsin; Cyclic AMP; Dexamethasone; Humans; In Vitro Techniques; Interleukin-13; Kinetics; Leukocytes, Mononuclear; Male; Phosphodiesterase Inhibitors; Phytohemagglutinins; Rolipram; Tetrazoles; Theophylline

2001
Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart.
    Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Interactions; Heart; Humans; Isoenzymes; Milrinone; Myocardium; Myocytes, Cardiac; Phosphodiesterase Inhibitors; Rabbits; Rolipram; Tetrazoles; Tissue Distribution

2002
Adenosine receptors and phosphodiesterase inhibitors stimulate Cl- secretion in Calu-3 cells.
    American journal of respiratory cell and molecular biology, 2003, Volume: 29, Issue:3 Pt 1

    Topics: Adenosine Deaminase; Anions; Cell Line; Chlorine; Cilostazol; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Electrophysiology; Epithelium; Glyburide; Humans; Hypoglycemic Agents; Milrinone; Mutation; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Purines; Receptors, Purinergic P1; Rolipram; Sildenafil Citrate; Sulfones; Tetrazoles; Time Factors

2003
Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol.
    Pulmonary pharmacology & therapeutics, 2008, Volume: 21, Issue:3

    Topics: Adrenergic beta-Agonists; Albuterol; Annexin A5; Anti-Inflammatory Agents; Apoptosis; Budesonide; Cell Survival; Cilostazol; DNA Fragmentation; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Neutrophils; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Purinones; Rolipram; Tetrazoles

2008
Inhibition of ATP release from erythrocytes: a role for EPACs and PKC.
    Microcirculation (New York, N.Y. : 1994), 2011, Volume: 18, Issue:2

    Topics: Adenine; Adenosine Triphosphate; Cilostazol; Colforsin; Cyclic AMP; Enzyme Activation; Erythrocytes; Guanine Nucleotide Exchange Factors; Humans; Iloprost; In Vitro Techniques; Isoproterenol; Models, Biological; Naphthalenes; Phosphodiesterase Inhibitors; Protein Kinase C; Rolipram; Signal Transduction; Tetradecanoylphorbol Acetate; Tetrazoles; Thionucleotides

2011
Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.
    Journal of the neurological sciences, 2012, Sep-15, Volume: 320, Issue:1-2

    Topics: Actins; Brain; Capillary Permeability; Carbazoles; Cells, Cultured; Cilostazol; Claudin-5; Dipyridamole; Drug Interactions; Electric Impedance; Endothelial Cells; Histamine; Humans; Isoquinolines; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Pyrroles; Rolipram; Sulfonamides; Tetrazoles

2012
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2012, Volume: 30, Issue:3

    Topics: Animals; Cell Differentiation; Cells, Cultured; Chemokine CXCL12; Cilostazol; Gene Expression Regulation; I-kappa B Kinase; Myelin Sheath; Oligodendroglia; Phosphodiesterase Inhibitors; Rats; Rolipram; Tetrazoles; Vinca Alkaloids

2012
Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment.
    The Journal of infectious diseases, 2013, Aug-01, Volume: 208, Issue:3

    Topics: Animals; Antitubercular Agents; Bacterial Load; Cilostazol; Disease Models, Animal; Drug Interactions; Humans; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phosphodiesterase Inhibitors; Piperazines; Purines; Rifampin; Rolipram; Sildenafil Citrate; Sulfones; Survival Analysis; Tetrazoles; Treatment Outcome; Tuberculosis

2013